Biochemical genetics concerning the biosynthesis of ABH blood group active glycoprotein, which has been disclosed mainly by outstanding workers, such as Iseki,1~ Morgan,2~ watkins,3> Ceppelini,4> etc., indicates that the action of A gene can be regarded as controlling the biosynthesis of a special kind of a-N-acetyl-D-galactosamine trans ferase, which catalizes the reaction between UDP-N-acetyl-D-galac tosamine and H substance, and so on. Thus it appears that the overall aspect of synthetic actions of ABH genes in isoantigen-producing cells can be estimated biochemically by assaying the content of intermediate (H) and terminal (A or B) isoantigens in them.
Recently we have succeeded in demonstrating H and A and/or B isoantigens in each tissue by histochemical method and obtained several inf ormations with respect to the specificity of biosynthesis of these isoantigens in normal and cancer cells. These results will be reported in this paper.
The experimental samples (surgical and autopsy specimens) were obtained from the First Department of Pathology, Teikyo University School of Medicine. All of them were fixed and preserved in f ormalin solution for a long time. They were cut, washed with water, immersed in gelatin aliquot and embedded in gelatin. Frozen section of a thickness of 7 ,u was prepared with the aid of cryostat and mounted on the slide. Mixed cell agglutination reaction (MCAR) was performed according to the original method of Davidsohn5~ with some modifications. The MCAR pattern was fixed by drying the specimens at 60°C and stained by usual benzidine method for the demonstration of MCAR positive indicator cells. The location of isoantigen could be stained distinctly with blue colour. The built-in controls were intrinsic erythrocytes, endothelial and epithelial linings in the examining specimens.
In considering the development of isoantigens in each tissue of the same individual of A, B or AB, following patterns of isoantigen manifestation of ABH, which are usually found, are recognized : Type 1: No isoantigen production (nerve cells, muscle fibers, etc.). of H (pancreatic acinus, intestinal mucosa, etc.). It is interesting to notice that some cells like those of duodenal and pyrolic glands of A, B and AB individuals, which are differentiated from the epithelial cell lining of cell type 3 or 4, belong to the type 2 ( Fig. 1, a and b) . Furthermore, it was confirmed also that the change of the epithelial linings from the gastric to duodenal mucosa is sometimes accompanied with the distinct transition of isoantigenic pattern of type 3 to 4. These facts suggest that the morphological differentiation is associated, not only with the synthesis of tissue-specific antigens, but also with the concomitant change of ABH isoantigenic behaviour of each cell. At the same time, it should be stressed that the cells in human body are not equivalent in synthesizing glycosyl transferases of ABO blood types, even though they are able to produce blood group active substance. Another experiment was performed to investigate the relationship between morphological differentiation (or dedifferentiation) of cells and concomitant change of their isoantigenic pattern in the case of carcinoma. One of the most interesting problems in recent oncology is the deletion of normal constituents (isozymes etc.) and appearance of abnormal substances (CEA, v-foetoprotein, etc.) in malignant cells. The ABH isoantigens in malignant cells have been intensively investigated by various pathologists. Previous reports on this problem are, however, contradictionary ; some indicate the loss of isoantigens and believe that the finding can be used for the early diagnosis of malignancy.5~ Recent reports,6> '7~ however, show that the isoantigenic activity is raised in several carcinomas. In referring our experimental results with 37 cases of gastric cancer with metastases and 17 cases of surgical specimens of cancer of urinary bladder, the complete loss of isoantigens is rare one ; the MCAR of malignant tissues gives the intrinsic isoantigen activity in many cases. Fig. 2 represents a case of gelatinous carcinoma of stomach, in which the biosynthesis of ABH isoantigens in the primary and metastatic lesions is increased enormously in comparing with that of normal mucosa, suggesting that all of glycosyl transferases of ABH isoantigens are produced in excess. This type of ABH producion in cancer cells occurs commonly in other cases of gelatinous cancer, so that some correlation between the isoantigen production and morphogenesis (differentiation) of malignant cells can be expected. [Vol. 55(B), Fig. 3 indicates the deletion of a-N-acetyl-D-galactosamine transf erase in the focal lesion (type 2) , which is located in the transitional carcinoma of urinary bladder of type 3. No morphological difference between both lesions was found, indicating the presence of aberrant clones in malignant tissues, which can be detected solely by investigating their isoantigenic behaviours.
In this sense, the histochemical examination of isoantigen specificity of cancer cells may be useful tool to determine the clone of impaired locus of ABH even at the early stage of malignancy.
Another example of the complexity of clonal developments in cancer tissue is the distribution of isoantigens of A and B in AB blood group. Such phenomena have been reported by Denk et a1.10 in the cases of gastric carcinoma. During the course of our experiment, we found a typical dissociation of A and B in one case of endometrial cancer of uterus (adenocarcinoma of moderate to high differentiation).
As shown in Fig. 4 , the tumor consists of at least two groups of isoantigen distribution;
i.e. that of (A+H) and of (A+B). It is interesting to notice that the area, where H is demonstrated, corresponds to the lesion of high differentiation with the lack of B activity. At the same time, another lesion is characterized by the impairment of H. Hence, this carcinoma contains at least two clonal series; that of impaired B gene at ABO locus and of impaired H gene at Hh locus. At present we have no conclusion whether the same carcinogenic agent stimulated the development of various types of clones or each clone demands its own factor for the development. The dissociation of serological behaviour and pathomorphology of the carcinoma, in addition, enhance the possibility that the deletion of genetic control itself relates with the malignancy of certain morphological entities. Finally, some precaution might be mentioned about the sensitivity of MCAR for the demonstration of H. It is commonly known that the attainment of the excellent reagent of Ulex europeus for this purpose is very difficult and the previous investigations with respect to the behaviour of H in malignant cells are not reliable. As the H is controlled by different locus from that of ABO, the lack of the exact informations about the behaviour of H is a serious defect to scope the overall aspect of biosynthesis of ABH. This difficulty is overcame by testing the specimens of frozen section. The affinity of the combination between indicator cells and fixed agglutinin is, when tested in this way, sufficient to sustain the MCAR, so that no difficulty is encountered in demonstrating the H activity with the routine Ulex anti-H (titer 1:128). 
